There was a significant downregulation of CDK2 (Fig. 7e) and a small change in p16 in the case of DOX alone and a significant upregulation in the case of CAN+DOX (Fig. 7f), but no changes were observed for the other drug combinations. This evidence concerns the gene CDK2 and Crouzon syndrome-acanthosis nigricans syndrome.